NCNA
NuCana plc
$1.95
-2.01%
$8.1M
No data for this timeframe.
Vol
Market Cap$8.1M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$24.8K
Inst. Activity0 buys / 1 sells
SEC Reports4
Press Releases1
Recent Activity
Jun 8, 2026
SEC
NuCana plc held its Annual General Meeting on June 8, 2026, and all resolutions proposed in the May 6, 2026 notice were
6-K — Impact 2/10
Jun 1, 2026
SEC
NuCana plc announced the appointment of Ian Webster as permanent Chief Financial Officer, effective June 1, 2026. Webste
6-K — Impact 3/10
Jun 1, 2026
earnings_calendar
NCNA Q1 2026 Earnings Scheduled — 2026-06-01
May 14, 2026
SEC
NuCana reported Q1 2026 results with a net loss of £3.9M, wider than the £2.5M loss in Q1 2025, driven by increased R&D
6-K — Impact 6/10
Apr 15, 2026
Insider
Bruce Theresa Margaret Ms was granted 132,600,130 shares
Chief Operating Officer
Inst.
MORGAN STANLEY — NEAR_EXIT
2 shares ($3.00)
Inst.
RHUMBLINE ADVISERS — DOUBLED
4,909 shares ($17.7K)
Mar 19, 2026
Press
NuCana reported financial results for Q4 and full-year 2025, showing increased net losses but a strengthened cash positi
Impact 6/10
Analyst Ratings
3Strong Buy
3Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 19, 2024 | Oppenheimer | REITERATE | Outperform → Outperform |
| Jul 23, 2024 | Oppenheimer | REITERATE | Outperform → Outperform |
| Jul 22, 2024 | Oppenheimer | MAINTAIN | Outperform → Outperform |
| Apr 1, 2024 | Oppenheimer | REITERATE | Outperform → Outperform |
| Nov 21, 2023 | Oppenheimer | REITERATE | Outperform → Outperform |
Latest Reports
NEUTRAL
6-K
2/10
NuCana plc held its Annual General Meeting on June 8, 2026, and all resolutions proposed in the May 6, 2026 notice were
Jun 8, 2026
NEUTRAL
6-K
3/10
NuCana plc announced the appointment of Ian Webster as permanent Chief Financial Officer, effective June 1, 2026. Webste
Jun 1, 2026
MIXED
Press
6/10
NuCana reported financial results for Q4 and full-year 2025, showing increased net losses but a strengthened cash positi
Mar 19, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $19.5K | — |
| RHUMBLINE ADVISERS | $5.2K | DOUBLED |
| MORGAN STANLEY | $3.00 | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 15, 2026 | Bruce Theresa | A | $0.00 |
3 institutional holders with $24.8K total value (17,579 shares) as of 2026-Q1. Top holders: CITADEL, RHUMBLINE, MORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 13,855 | $19.5K | 78.8% | — |
| 2 | RHUMBLINE ADVISERS | 3,722 | $5.2K | 21.2% | DOUBLED +891.7% |
| 3 | MORGAN STANLEY | 2 | $3.00 | 0.0% | NEAR_EXIT -98.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | NEAR_EXIT | 105 | 2 | -98.1% | $3.00 | 2026-Q1 |
| RHUMBLINE ADVISERS | DOUBLED | 495 | 4,909 | +891.7% | $17.7K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 2 | 105 | +5150.0% | $378.00 | 2025-Q4 |
| RHUMBLINE ADVISERS | DOUBLED | 1,822 | 8,072 | +343.0% | $459.00 | 2025-Q2 |
| RHUMBLINE ADVISERS | ADD | 1,345 | 1,822 | +35.5% | $1.6K | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 5,044 | 12,313 | +144.1% | $14.7K | 2024-Q4 |
| UBS Group AG | NEAR_EXIT | 12,604 | 6 | -100.0% | $7.00 | 2024-Q4 |
| BAILLIE GIFFORD & CO | TRIM | 146,360 | 36,704 | -74.9% | $84.4K | 2024-Q3 |
| MORGAN STANLEY | DOUBLED | 1,564 | 5,044 | +222.5% | $11.6K | 2024-Q3 |
1 unique insiders with 1 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Bruce Theresa Margaret Ms | Chief Operating Officer | AWARD | 132,600,130 | — | — |
4 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
NEUTRAL
6-K
2/10
NuCana plc held its Annual General Meeting on June 8, 2026, and all resolutions proposed in the May
Jun 8, 2026
NEUTRAL
6-K
3/10
NuCana plc announced the appointment of Ian Webster as permanent Chief Financial Officer, effective
Jun 1, 2026
BULLISH
6-K
6/10
NuCana reported Q1 2026 results with a net loss of £3.9M, wider than the £2.5M loss in Q1 2025, driv
May 14, 2026
BEARISH
6-K
5/10
NuCana published its 2025 UK Annual Report, reporting a net loss of £29.4M vs £19.0M in 2024, driven
May 6, 2026
Historical analyst distribution (last covering-analyst action Aug 2024): 75% buy across 8 analysts — 3 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
7 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 6 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 19, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Jul 23, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Jul 22, 2024 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Apr 1, 2024 | Oppenheimer | REITERATE | Outperform | Outperform |
| Nov 21, 2023 | Oppenheimer | REITERATE | Outperform | Outperform |
| Sep 6, 2023 | Truist Securities | REITERATE | Buy | Buy |
| Aug 18, 2023 | Oppenheimer | REITERATE | Outperform | Outperform |
| May 22, 2023 | Oppenheimer | REITERATE | Outperform | Outperform |
| Sep 22, 2022 | Jefferies | MAINTAIN | — | Buy |
| Mar 3, 2022 | Cowen & Co. | DOWNGRADE | Outperform | Market Perform |
| Nov 24, 2021 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Dec 1, 2020 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Nov 24, 2020 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Oct 22, 2020 | Truist Securities | INITIATE | — | Buy |
| Aug 21, 2020 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Jul 24, 2020 | Oppenheimer | INITIATE | — | Outperform |
| Mar 11, 2020 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Nov 15, 2019 | HC Wainwright & Co. | REITERATE | — | Buy |
| Aug 19, 2019 | HC Wainwright & Co. | INITIATE | — | Buy |
| Oct 19, 2018 | Piper Sandler | INITIATE | — | Overweight |
| Oct 23, 2017 | Citigroup | INITIATE | — | Buy |
| Oct 23, 2017 | Cowen & Co. | INITIATE | — | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2025 | 3 | 3 | 2 | 0 | 0 | 75% | |
| May 1, 2025 | 3 | 3 | 2 | 0 | 0 | 75% | |
| Apr 1, 2025 | 3 | 3 | 2 | 0 | 0 | 75% | |
| Mar 1, 2025 | 3 | 3 | 3 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 1, 2026
earnings_calendar
NCNA Q1 2026 Earnings Scheduled — 2026-06-01
May 14, 2026
earnings
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update
<p align="center"><strong><em>Final Data from Phase 2 Expansion Study of NUC-7738 Expected in 2026</em></strong></p>
Mar 19, 2026
earnings
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
<p align="center"><strong><em>NUC-7738 Demonstrates Clinical Activity and Favorable Safety in Patients with PD-1 Inhibitor-Resistant Melanoma</em></st
Mar 18, 2026
earnings_calendar
NCNA Q4 2025 Earnings After Market Close — 2026-03-18